Compounds > n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine
Page last updated: 2024-09-03

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Hypercapnia

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with Hypercapnia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duncan, R; Heal, A; Karatzas, ND; Kung, HF; Pappas, D; Serafini, A; Sfakianakis, GN1

Other Studies

1 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Hypercapnia

ArticleYear
Experimental increase in brain HIPDM uptake by hypercapnia.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1988, Volume: 29, Issue:10

    Topics: Animals; Body Weight; Brain; Cerebrovascular Circulation; Hypercapnia; Iodine Radioisotopes; Iodobenzenes; Male; Rats; Rats, Inbred Strains; Tomography, Emission-Computed

1988